MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202647067444 A) filed by Eisai R&d Management Co. , Ltd. on May 29, 2026, for Antisense Oligonucleotides And Their Use For Treatment Of Neurodegenerative Disorders.
Inventors include Fang, Francis G.; Easley-Neal, Courtney; Mitasev, Branko; Vathipadiekal, Vinod; Wang, John; Choi, Hyeong Wook; and Lee, Jung Hwa.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: Novel antisense oligonucleotides that induce Exon-2 skipping in the CD33 gene during pre-mRNA splicing, and their use in the treatment of a neurodegenerative disease, such as Alzheimer's disease, are disclosed.
Disclaimer: Curated by HT Syndication.
